Cyclohexanemethylamine → HCID 25214731, Verbindung
Reaktionsgleichung
Cl[C:2]1[N:7]2[N:8]=[C:9]([NH:11][C:12](=[O:19])[C:13]3[CH:18]=[CH:17][CH:16]=[N:15][CH:14]=3)[N:10]=[C:6]2[CH:5]=[C:4]([C:20]([F:23])([F:22])[F:21])[CH:3]=1.[CH:24]1([CH2:30][NH2:31])[CH2:29][CH2:28][CH2:27][CH2:26][CH2:25]1>>[CH:24]1([CH2:30][NH:31][C:2]2[N:7]3[N:8]=[C:9]([NH:11][C:12](=[O:19])[C:13]4[CH:18]=[CH:17][CH:16]=[N:15][CH:14]=4)[N:10]=[C:6]3[CH:5]=[C:4]([C:20]([F:23])([F:22])[F:21])[CH:3]=2)[CH2:29][CH2:28][CH2:27][CH2:26][CH2:25]1Komponenten
3
Versuchsvorschrift
The title compound was prepared following procedure described for example 76 but starting from N-[5-chloro-7-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyridin-2-yl]nicotinamide ((B7), 50 mg; 0.14 mmol; 1.0 eq.) and cyclohexanemethylamine (500 μl) as a white powder (27 mg; 44%). HPLC, Rt: 4.11 min. (purity 99.8%). LC/MS, M+(ESI): 419.4, M−(ESI): 417.4.
Quellen und Nachweise
- ORD-Eintrag
- ord-a6a4acaab80c4dd080018f227b52b855
- Quelldatensatz
- uspto-grants-2012_09
- Patentnummer